R-Smoking SPRL
Dissolution volontaire – liquidationR-Smoking reported total assets of 654,011 € at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026).
The score of R-Smoking shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +3 % Total assets -24 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
R-Smoking's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 24 Nov 2025
- Year ended 31 Mar 2024filed on 21 Oct 2024
- Year ended 31 Mar 2023filed on 31 Oct 2023
- Year ended 31 Mar 2022filed on 28 Sep 2022
R-Smoking's financial analysis
- Solvency99.3%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of R-Smoking
R-Smoking's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0872.342.576
- VAT number
- BE0872342576
- Peppol
- Registered · 0208:0872342576 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 07 Mar 2005
- Registered office
- 4340 Awans
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
R-Smoking (SPRL) has been based in Awans since 2005, active in: wholesale of pharmaceutical and medical goods. For 2026, it reports a net profit of 10,247 € and equity of 649,533 €; its revenue is not published. Its solvency stands at 99.3%, above the median of its sector (44.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to R-Smoking
Companies in the same business, of comparable size and area, outside its group.
- Honeypatch Manufacture of pharmaceutical preparations Liège · balance sheet 330,409 €
- I&L Biosystems Belgium Wholesale of pharmaceutical and medical goods Leuven · balance sheet 576,883 €
- Dr. de Weerd Pigeons World Wide Wholesale of pharmaceutical and medical goods Brasschaat · balance sheet 776,604 €
- Medical Promotion Wholesale of pharmaceutical and medical goods Jodoigne · balance sheet 842,684 €
- Feton Wholesale of pharmaceutical and medical goods Uccle · balance sheet 806,088 €
- Providental Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 517,153 €
- Care for Health Wholesale of pharmaceutical and medical goods Ghent · balance sheet €1.00m
- Distriphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.09m
Frequently asked questions about R-Smoking
What is the revenue of R-Smoking?
R-Smoking files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of R-Smoking?
In Belgium, the VAT number is the company number prefixed with BE: BE0872342576 for R-Smoking, if the company is VAT-registered. Its company number (CBE) is 0872.342.576.
Where is the registered office of R-Smoking?
According to the CBE register, the registered office of R-Smoking is in 4340 Awans.
What is the equity of R-Smoking?
At the close of the 2026 financial year, the equity of R-Smoking amounts to 649,533 €, a solvency of 99.3% of total assets.
Who manages R-Smoking?
The register lists 2 active mandates at R-Smoking. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of R-Smoking
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →